Search Within

Daniel Hirschhorn Cymerman

Formats
  1. Journal Article (24)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (48)
  2. Sloan Kettering Institute Postdocs (48)
  3. GSK Faculty (47)
  4. Melanoma and Immunotherapeutics Service (46)
  5. Solid Tumor Oncology Division (46)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Taha Merghoub (42)
  2. Jedd Wolchok (41)
  3. Sadna Budhu (20)
  4. Alan Houghton (19)
  5. Cailian Liu (16)
  6. Roberta Zappasodi (12)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (4)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (6)

More Years

Publications
  1. Cancer Research (7)
  2. Journal for ImmunoTherapy of Cancer (6)
  3. Journal of Immunology (6)
  4. Blood (4)
  5. Journal of Experimental Medicine (4)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. Biomed Central Ltd (6)
  3. The American Association of Immunologists, Inc (6)
  4. American Society of Hematology (4)
  5. Rockefeller University Press (4)
  6. Cell Press (3)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model
    Meeting Abstract

    Schad, S.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; Yang, X.; Merghoub, T.; Wolchok, J. D.
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Immuno-PET imaging of activation markers on antigen-specific CD4 T cells in a mouse model of melanoma
    Meeting Abstract

    Krebs, S.; Carter, L.; Hirschhorn-Cymerman, D.; Wolchok, J.; Merghoub, T.; Schoder, H.; Larson, S.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Treatment with agonist anti-GITR antibody after chemotherapy enhances tumor immunity
    Meeting Abstract

    Warner, A. B.; Hirschhorn, D.; Cohen, A.; Liu, C.; Newman, W.; Sirard, C.; Wolchok, J.; Merghoub, T.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody enhances antitumor activity of CAR T cells in mouse melanoma
    Meeting Abstract

    Schad, S.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; Yang, X.; Shan, J.; King, S.; Merghoub, T.; Wolchok, J.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; DeHanau, O.; Mangarin, L. M.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save